Host determinants in HIV infection and disease. Part 2: genetic factors and implications for antiretroviral therapeutics.
about
Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infectionCardiovascular disease in human immunodeficiency virus infected patients: A true or perceived risk?Resistance to HIV InfectionIncreased cardiovascular disease risk in the HIV-positive population on ART: potential role of HIV-Nef and TatMarkers of viral infection in monozygotic twins discordant for chronic fatigue syndromeMonocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion.Disease Progression Among Untreated HIV-Infected Patients in South Ethiopia: Implications for Patient CareRapid escape from preserved cross-reactive neutralizing humoral immunity without loss of viral fitness in HIV-1-infected progressors and long-term nonprogressorsHIV gp120 induces endothelial dysfunction in tumour necrosis factor-alpha-activated porcine and human endothelial cellsThe relationship between antibody to R7V and progression of HIV type 1 infectionThe pharmacogenomics of HIV therapy.Dendritic cell-mediated HIV-1 infection of T cells demonstrates a direct relationship to plasma viral RNA levelsPartial protective effect of CCR5-Delta 32 heterozygosity in a cohort of heterosexual Italian HIV-1 exposed uninfected individuals.Inflammatory mediators and reversible myocardial dysfunction.CCR5: From Natural Resistance to a New Anti-HIV Strategy.The role of sexually transmitted diseases in HIV transmission.Acute HIV revisited: new opportunities for treatment and prevention.CCR5 expression is elevated on endocervical CD4+ T cells in healthy postmenopausal women.Predictors of disease progression in HIV infection: a review.Variable effect of co-infection on the HIV infectivity: within-host dynamics and epidemiological significance.Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma.In vitro characterization of multidrug-resistant HIV-1 isolates from a recently infected patient associated with dual tropism and rapid disease progressionGenetic determinants of HIV-1 infection and progression to AIDS: immune response genes.CCR5 expression is reduced in lymph nodes of HIV type 1-infected women, compared with men, but does not mediate sex-based differences in viral loads.Inducible nitric oxide synthase (iNOS) gene polymorphism and disease prevalence.Toward the discovery of novel anti-HIV drugs. Second-generation inhibitors of the cellular ATPase DDX3 with improved anti-HIV activity: synthesis, structure-activity relationship analysis, cytotoxicity studies, and target validation.Gene-expression profiling of HIV-1 infection and perinatal transmission in Botswana.Maternal plasma and breastmilk viral loads are associated with HIV-1-specific cellular immune responses among HIV-1-exposed, uninfected infants in Kenya.CXCR4 receptor antagonist blocks cardiac myocyte p38 MAP kinase phosphorylation by HIV gp120.Copy number variations of CCL3L1 and long-term prognosis of HIV-1 infection in asymptomatic HIV-infected Japanese with hemophilia.Stromal cell-derived factor 1 (SDF1) genetic polymorphism in a sample of healthy individuals, seronegative individuals exposed to human immunodeficiency virus type 1 (HIV-1) and patients infected with HIV-1 from the Brazilian population.Socio-demographic and epidemiological characteristics associated with human immunodeficiency virus type I (HIV-1) infection in HIV-1-exposed but uninfected individuals, and in HIV-1-infected patients from a southern Brazilian population.The Role of Natural Antibodies to CC Chemokine Receptor 5 in HIV Infection.Association of highly active antiretroviral therapy failure with chemokine receptor 5 wild type.Primary HIV Infection.CCTTT-repeat polymorphism of the inducible nitric oxide synthase is not associated with HIV pathogenesisDisease progression among untreated HIV-infected patients in South Ethiopia: implications for patient careAssociation between HIV-1 RNA level and CD4 cell count among untreated HIV-infected individuals
P2860
Q24536249-FA3A8BBF-97DC-4D09-A1FC-23F9EBA4A263Q26777866-336E7004-F450-4CBA-A90E-7EB57AA591BFQ27473466-1F5F50E8-5411-46E8-B2F5-4ABD1CD2DA28Q28080948-8DFEBDA8-2659-40A5-9088-2C0AE85C8A78Q28217481-E7F47575-6A00-4105-8ED1-80F0D72A4D28Q33238490-946AD55D-C83B-417D-B45F-E47F8C1E4969Q33583293-F72685D3-A2EE-449C-ACE4-155000BFBBE0Q33725673-0D00A814-5D2E-4A27-9124-BBC466631F3AQ33954940-AC0E8188-F114-4C93-9F13-C4B230BAEC0DQ34103197-F6EC7B92-EF23-45A5-B876-6A5AEF2B3377Q34574033-EAB4ADF5-96F6-4170-A187-BF1F01C13F13Q34910224-EF6F7380-6849-4A05-B9EF-CCDB2A3C2637Q35069318-D6B03E0D-FA0B-4176-A807-C6C25C6CF8BDQ35071231-1F8CA4F5-BD53-4CFD-AC9A-44B9FC1905BAQ35260605-6288C1D3-AC65-45BB-A1F4-E56EEEBCAE03Q35701598-F787F3EE-2079-4BF6-AF84-08B9AB816117Q35730339-DE404D85-E8CE-4F5D-BA1D-0FC257FDF0D4Q35784816-C84DC33B-19CB-4812-8054-4FC2B653461CQ35834337-23827456-AC8A-4E88-A238-2DFE2A11BAB1Q35914310-9A47B19D-8E0A-40FF-A2CE-26A083B3071EQ36879697-9975FF31-AFFE-40DA-97EF-D30A30BC8D20Q37051661-A5F6BB1B-688D-437D-A8F2-10CF8447728BQ37599963-2519089E-DE40-465F-8788-D4723138D75FQ37604457-D02F5AD3-2255-47EE-ACF3-F06B96F3983DQ37805621-94A871E6-0663-442C-9C29-E3D6A445E7D7Q39519625-DD6A41C0-A7E0-4FD7-B589-B7F206D724AFQ40799780-9CC95AC5-E9E1-4CC2-9D9B-87277501E847Q41478363-27E6458A-295B-4C97-A48D-D663A234DF68Q44941992-EC54E6B0-8F3F-4D8F-85C5-3EAF950B6A47Q45145428-1ED2C21F-5030-482B-AA3E-3791916E1C05Q45417759-8C63A335-54F0-4D5B-AA7E-56CDA5CA593AQ45422302-FEEB3864-140A-480E-839F-9AC609F0E6DDQ47107303-2DAFFFCA-97F0-4167-9AD6-2E8D8E4DB10DQ47242107-BF875EAD-C045-4702-B3B3-D848135D4A11Q53781581-84CF4F16-267A-42E8-9613-0AC42A21E0B2Q56930467-1859D258-91A6-47A4-B683-1455A129A235Q57005754-FC0AFEEF-7387-4484-9682-11A792C7C42AQ57259624-0EC1D54A-5F35-428D-8A9E-02C62558FB12
P2860
Host determinants in HIV infection and disease. Part 2: genetic factors and implications for antiretroviral therapeutics.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Host determinants in HIV infec ...... r antiretroviral therapeutics.
@ast
Host determinants in HIV infec ...... r antiretroviral therapeutics.
@en
Host determinants in HIV infec ...... r antiretroviral therapeutics.
@nl
type
label
Host determinants in HIV infec ...... r antiretroviral therapeutics.
@ast
Host determinants in HIV infec ...... r antiretroviral therapeutics.
@en
Host determinants in HIV infec ...... r antiretroviral therapeutics.
@nl
prefLabel
Host determinants in HIV infec ...... r antiretroviral therapeutics.
@ast
Host determinants in HIV infec ...... r antiretroviral therapeutics.
@en
Host determinants in HIV infec ...... r antiretroviral therapeutics.
@nl
P1476
Host determinants in HIV infec ...... r antiretroviral therapeutics.
@en
P2093
P304
P356
10.7326/0003-4819-134-10-200105150-00012
P407
P577
2001-05-01T00:00:00Z